Yield10 Bioscience, Inc. (YTEN) NASDAQ

Currency In USD

AD

Valuation

Market Cap1.9M
Enterprise Value4.04M
P/E Ratio-0.01
PEG Ratio-0
Price/Sales Ratio5.76
Price/Book Ratio-0.04
Enterprise/Revenue41.37
Enterprise/EBITDA-0.18

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-240.92
Operating Margin-240.28
AD

Management Effectiveness

Return On Assets-3.7
Return On Equity-15.08

Income Statement

Revenue60,000
Revenue/Share0.18
Gross Profit-230,000
EBITDA-14.13M
Net Income-14.46M
Diluted EPS-43.66

Balance Sheet

Total Cash733,000
Total Cash/Share3.23
Total Debt2.79M
Total Debt/Equity-1.29
Current Ratio0.29
Book Value Per Share-7.5

Price History

52-Week Change-93.22
52-Week High17.26
52-Week Low0.24
Moving Average 50 Days0.56
Moving Average 200 Days2.34

Statistics

Average Volume5,094
Shares Outstanding1.03M
% Held by Institutions12.63

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:24
Last Split DateMay 03, 2024
AD